XNCR (Xencor) Inventories, Raw Materials & Components: $0.00 Mil (As of Mar. 2026)


XNCR Xencor Inc XNCR
52 GF Score
Price $14.94
GF Value $9.56
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Xencor Inventories, Raw Materials & Components?

Xencor XNCR -2.86% 52 Inventories, Raw Materials & Components is $0.00 Mil as of Mar. 2026. GuruFocus rates XNCR with a GF Score™ of 52/100 and a GF Value™ of $9.56 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Xencor's inventories, raw materials & components for the quarter that ended in Mar. 2026 was $0.00 Mil.

Xencor Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Xencor's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xencor Inventories, Raw Materials & Components Chart

Xencor Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Xencor Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XNCR
52GF Score
Xencor Inc XNCR
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xencor Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $0.00 Mil mean?
Xencor (XNCR) has a Inventories, Raw Materials & Components of $0.00 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Xencor and its competitors.
Is Xencor's Inventories, Raw Materials & Components too high?
Xencor's current Inventories, Raw Materials & Components is $0.00 Mil. Overall, Xencor has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Xencor's Inventories, Raw Materials & Components compare to MGTX and WVE?
Xencor's Inventories, Raw Materials & Components of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Xencor and its competitors. Xencor's current Inventories, Raw Materials & Components is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xencor stock overvalued right now?
Based on GuruFocus' analysis, Xencor (XNCR) is currently considered Significantly Overvalued. The stock's GF Value™ is $9.56, compared to a current price of $14.94 — trading 56.3% above its estimated fair value. The current Inventories, Raw Materials & Components is $0.00 Mil. Xencor's overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Xencor (XNCR), the current Inventories, Raw Materials & Components is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xencor (XNCR) Overvalued in 2026?

Based on GuruFocus' analysis, Xencor stock appears to be overvalued. The current stock price of $14.94 is trading 56.3% above its estimated GF Value™ of $9.56. GuruFocus considers Xencor to be Significantly Overvalued.

Key valuation signals for XNCR:

  • Inventories, Raw Materials & Components: $0.00 Mil
  • GF Value™: $9.56 vs. price of $14.94 (56.3% above fair value)
  • GF Score™: 52/100 with 7 warning signs

No single metric tells the full story. See the XNCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Xencor Business Description

Other Exchanges XE9:Germany
Address 465 North Halstead Street, Suite 200, Pasadena, CA, USA, 91107
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
52GF Score

Get the complete analysis for XNCR

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.94
Price
$9.56
GF Value